PRPO

Precipio (PRPO)

About Precipio (PRPO)

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Details

Daily high

$5.46

Daily low

$5.22

Price at open

$5.36

52 Week High

$7.30

52 Week Low

$4.31

Market cap

7.8M

Dividend yield

0.00%

Volume

2,600

Avg. volume

5,847

P/E ratio

-2.55

Precipio News